Clinical trials
Completed Phase 2 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
942 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 24 |
| 2001 | 22 |
| 2002 | 38 |
| 2003 | 51 |
| 2004 | 56 |
| 2005 | 59 |
| 2006 | 71 |
| 2007 | 47 |
| 2008 | 64 |
| 2009 | 57 |
| 2010 | 29 |
| 2011 | 39 |
| 2012 | 29 |
| 2013 | 40 |
| 2014 | 22 |
| 2015 | 35 |
| 2016 | 26 |
| 2017 | 44 |
| 2018 | 27 |
| 2019 | 33 |
| 2020 | 20 |
| 2021 | 28 |
| 2022 | 16 |
| 2023 | 7 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 942 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 63 |
| National Cancer Institute (NCI) | 45 |
| Pfizer | 24 |
| Alliance for Clinical Trials in Oncology | 23 |
| M.D. Anderson Cancer Center | 21 |
| Memorial Sloan Kettering Cancer Center | 18 |
| Hoffmann-La Roche | 16 |
| AstraZeneca | 15 |
| Novartis Pharmaceuticals | 15 |
| SCRI Development Innovations, LLC | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 942 |
| Lung Neoplasms | 333 |
| Adenocarcinoma of Lung | 74 |
| Neoplasms | 49 |
| Adenocarcinoma, Bronchiolo-Alveolar | 41 |
| Neoplasm Metastasis | 32 |
| Small Cell Lung Carcinoma | 31 |
| Breast Neoplasms | 27 |
| Brain Neoplasms | 20 |
| Carcinoma | 17 |
Trials
Showing 1 to 25 of 942. Each trial links to its page on Pharma Observatory.
842 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.